Position in MDWD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,401,123
+$148,918 QoQ
Shares Held
273,192
+18.6% QoQ
Ownership
2.13%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDWD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SPHERA FUNDS MANAGEMENT LTD. holds $325,221,568 across 61 Biotechnology names. MDWD ranks #27 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
1,339,971 | $36,299,814 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
245,246 | $18,211,967 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
809,333 | $16,955,526 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
724,563 | $16,925,791 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
416,340 | $16,024,926 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
603,377 | $8,724,831 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
214,914 | $8,645,990 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
139,900 | $7,902,951 |
All Filings in MDWD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,401,123 | 273,192 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,252,205 | 230,347 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,338,565 | 185,270 | Shares | Defined | 2025-11-14 | |
| 2023-12-31 | $498,126 | 48,980 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $1,154,790 | 108,533 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,184,613 | 111,127 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,480,211 | 111,127 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,017,321 | 75,413 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||